{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T21:18:24Z","timestamp":1773695904507,"version":"3.50.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T00:00:00Z","timestamp":1605225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T00:00:00Z","timestamp":1605225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s11033-020-05988-1","type":"journal-article","created":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T09:09:03Z","timestamp":1605258543000},"page":"9939-9949","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Potential approaches to combat COVID-19: a mini-review"],"prefix":"10.1007","volume":"47","author":[{"given":"Zainab","family":"Sarwar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2650-6950","authenticated-orcid":false,"given":"Tahir","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salik","family":"Kakar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,13]]},"reference":[{"key":"5988_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0331-4","author":"M Merad","year":"2020","unstructured":"Merad M, Martin JC (2020) Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol. https:\/\/doi.org\/10.1038\/s41577-020-0331-4","journal-title":"Nat Rev Immunol"},{"key":"5988_CR2","doi-asserted-by":"publisher","first-page":"313","DOI":"10.4014\/jmb.2003.03011","volume":"30","author":"D-G Ahn","year":"2020","unstructured":"Ahn D-G, Shin H-J, Kim M-H et al (2020) Current status of epidemiology, diagnosis, therapeutics, and vaccines for novel coronavirus disease 2019 (COVID-19). J Microbiol Biotechnol 30:313\u2013324. https:\/\/doi.org\/10.4014\/jmb.2003.03011","journal-title":"J Microbiol Biotechnol"},{"key":"5988_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fbioe.2020.00916","volume":"8","author":"H Uluda\u011f","year":"2020","unstructured":"Uluda\u011f H, Parent K, Aliabadi HM, Haddadi A (2020) Prospects for RNAi therapy of COVID-19. Front Bioeng Biotechnol 8:1\u201315. https:\/\/doi.org\/10.3389\/fbioe.2020.00916","journal-title":"Front Bioeng Biotechnol"},{"key":"5988_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12575-020-00128-2","volume":"22","author":"H Esakandari","year":"2020","unstructured":"Esakandari H, Nabi-Afjadi M, Fakkari-Afjadi J et al (2020) A comprehensive review of COVID-19 characteristics. Biol Proced Online 22:1\u201310. https:\/\/doi.org\/10.1186\/s12575-020-00128-2","journal-title":"Biol Proced Online"},{"key":"5988_CR5","unstructured":"World Health Organization (2020) Coronavirus Disease (COVID-19) Weekly Operational Update. https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/situation-reports\/20200928-weekly-epi-update.pdf?sfvrsn=9e354665_6. Accessed 3 Oct 2020"},{"issue":"7816","key":"5988_CR6","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41586-020-2286-9","volume":"583","author":"DE Gordon","year":"2020","unstructured":"Gordon DE, Jang GM, Bouhaddou M et al (2020) A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature 583(7816):459\u2013468. https:\/\/doi.org\/10.1038\/s41586-020-2286-9","journal-title":"Nature"},{"key":"5988_CR7","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/d41586-020-01221-y","volume":"580","author":"E Callaway","year":"2020","unstructured":"Callaway E (2020) The race for coronavirus vaccines: a graphical guide. Nature 580:576\u2013577","journal-title":"Nature"},{"key":"5988_CR8","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1126\/science.368.6486.14","volume":"368","author":"J Cohen","year":"2020","unstructured":"Cohen J (2020) Vaccine designers take first shots at COVID-19. Science 368:14\u201317. https:\/\/doi.org\/10.1126\/science.368.6486.14","journal-title":"Science"},{"key":"5988_CR9","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/d41573-020-00073-5","volume":"19","author":"T Thanh Le","year":"2020","unstructured":"Thanh Le T, Andreadakis Z, Kumar A et al (2020) The COVID-19 vaccine development landscape. Nat Rev Drug Discov 19:305\u2013306. https:\/\/doi.org\/10.1038\/d41573-020-00073-5","journal-title":"Nat Rev Drug Discov"},{"key":"5988_CR10","doi-asserted-by":"publisher","first-page":"343","DOI":"10.4110\/in.2017.17.5.343","volume":"17","author":"MC Kang","year":"2017","unstructured":"Kang MC, Park HW, Choi DH et al (2017) Plasmacytoid dendritic cells contribute to the protective immunity induced by intranasal treatment with fc-fused interleukin-7 against lethal influenza virus infection. Immune Netw 17:343\u2013351. https:\/\/doi.org\/10.4110\/in.2017.17.5.343","journal-title":"Immune Netw"},{"issue":"14","key":"5988_CR11","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.1111\/bph.15092","volume":"177","author":"H Zhou","year":"2020","unstructured":"Zhou H, Fang Y, Xu T et al (2020) Potential therapeutic targets and promising drugs for combating SARS-CoV-2. Br J Pharmacol 177(14):3147\u20133161. https:\/\/doi.org\/10.1111\/bph.15092","journal-title":"Br J Pharmacol"},{"issue":"7","key":"5988_CR12","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1017\/CBO9781107415324.004","volume":"11","author":"Y Shibo Jiang","year":"2005","unstructured":"Shibo Jiang Y, He and SL, (2005) SARS vaccine development. Emerg Infect Dis 11(7):1016\u20131020. https:\/\/doi.org\/10.1017\/CBO9781107415324.004","journal-title":"Emerg Infect Dis"},{"key":"5988_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/21645515.2020.1735227","volume":"00","author":"K Dhama","year":"2020","unstructured":"Dhama K, Sharun K, Tiwari R et al (2020) COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics. Hum Vaccines Immunother 00:1\u20137. https:\/\/doi.org\/10.1080\/21645515.2020.1735227","journal-title":"Hum Vaccines Immunother"},{"key":"5988_CR14","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nrmicro2090","volume":"7","author":"L Du","year":"2009","unstructured":"Du L, He Y, Zhou Y et al (2009) The spike protein of SARS-CoV\u2014a target for vaccine and therapeutic development. Nat Rev Microbiol 7:226\u2013236. https:\/\/doi.org\/10.1038\/nrmicro2090","journal-title":"Nat Rev Microbiol"},{"key":"5988_CR15","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jinf.2005.07.023","volume":"51","author":"BR Panhotra","year":"2005","unstructured":"Panhotra BR, Bahrani A, Joshi CS, ul Hassan Z (2005) Occult hepatitis B virus infection among anti-HBc positive blood donors: necessitates substitution of screening by HBV NAT. J Infect 51:263. https:\/\/doi.org\/10.1016\/j.jinf.2005.07.023","journal-title":"J Infect"},{"key":"5988_CR16","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1002\/jmv.25707","volume":"92","author":"L Zhang","year":"2020","unstructured":"Zhang L, Liu Y (2020) Potential interventions for novel coronavirus in China: a systematic review. J Med Virol 92:479\u2013490. https:\/\/doi.org\/10.1002\/jmv.25707","journal-title":"J Med Virol"},{"key":"5988_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0144475","volume":"10","author":"J Shi","year":"2015","unstructured":"Shi J, Zhang J, Li S et al (2015) Epitope-based vaccine target screening against highly pathogenic MERS-CoV: an in silico approach applied to emerging infectious diseases. PLoS ONE 10:1\u201316. https:\/\/doi.org\/10.1371\/journal.pone.0144475","journal-title":"PLoS ONE"},{"key":"5988_CR18","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1109\/TCBB.2017.2702588","volume":"15","author":"Q Xie","year":"2018","unstructured":"Xie Q, He X, Yang F et al (2018) Analysis of the genome sequence and prediction of B-Cell epitopes of the envelope protein of middle east respiratory syndrome-coronavirus. IEEE\/ACM Trans Comput Biol Bioinform 15:1344\u20131350. https:\/\/doi.org\/10.1109\/TCBB.2017.2702588","journal-title":"IEEE\/ACM Trans Comput Biol Bioinform"},{"key":"5988_CR19","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/nrmicro3143","volume":"11","author":"RL Graham","year":"2013","unstructured":"Graham RL, Donaldson EF, Baric RS (2013) A decade after SARS: strategies for controlling emerging coronaviruses. Nat Rev Microbiol 11:836\u2013848. https:\/\/doi.org\/10.1038\/nrmicro3143","journal-title":"Nat Rev Microbiol"},{"key":"5988_CR20","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3390\/VACCINES8020153","volume":"8","author":"J Zhang","year":"2020","unstructured":"Zhang J, Zeng H, Gu J et al (2020) Progress and prospects on vaccine development against SARS-CoV-2. Vaccines 8:153. https:\/\/doi.org\/10.3390\/VACCINES8020153","journal-title":"Vaccines"},{"key":"5988_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2020.01258","volume":"11","author":"RP Saha","year":"2020","unstructured":"Saha RP, Sharma AR, Singh MK et al (2020) Repurposing drugs, ongoing vaccine, and new therapeutic development initiatives against COVID-19. Front Pharmacol 11:1\u201333. https:\/\/doi.org\/10.3389\/fphar.2020.01258","journal-title":"Front Pharmacol"},{"key":"5988_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pathogens9020148","volume":"9","author":"B Shanmugaraj","year":"2020","unstructured":"Shanmugaraj B, Malla A, Phoolcharoen W (2020) Emergence of novel coronavirus 2019-nCoV: need for rapid vaccine and biologics development. Pathogens 9:1\u201310. https:\/\/doi.org\/10.3390\/pathogens9020148","journal-title":"Pathogens"},{"key":"5988_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2019.12.003","author":"Z Jahanafrooz","year":"2019","unstructured":"Jahanafrooz Z, Baradaran B, Mosafer J, Hashemzaei M, Rezaei T, Mokhtarzadeh AHM (2019) Comparison of DNA and mRNA vaccines against cancer. Drug Discov Today. https:\/\/doi.org\/10.1016\/j.drudis.2019.12.003","journal-title":"Drug Discov Today"},{"key":"5988_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12659\/MSM.924700","volume":"26","author":"F Wang","year":"2020","unstructured":"Wang F, Kream RM, Stefano GB (2020) An evidence based perspective on mRNA-SARScov-2 vaccine development. Med Sci Monit 26:1\u20138. https:\/\/doi.org\/10.12659\/MSM.924700","journal-title":"Med Sci Monit"},{"issue":"9","key":"5988_CR25","doi-asserted-by":"publisher","first-page":"825","DOI":"10.3390\/v11090825","volume":"11","author":"EAJ Alsaadi","year":"2019","unstructured":"Alsaadi EAJ, Neuman BW, Jones IM (2019) A fusion peptide in the spike protein of MERS coronavirus. Viruses 11(9):825. https:\/\/doi.org\/10.3390\/v11090825","journal-title":"Viruses"},{"key":"5988_CR26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jsb.2010.11.021","volume":"174","author":"BW Neuman","year":"2010","unstructured":"Neuman BW, Kiss G, Kunding AH et al (2010) A structural analysis of M protein in coronavirus assembly and morphology. J Struct Biol 174:11\u201322. https:\/\/doi.org\/10.1016\/j.jsb.2010.11.021","journal-title":"J Struct Biol"},{"issue":"Pt 10","key":"5988_CR27","doi-asserted-by":"publisher","first-page":"3109","DOI":"10.1099\/vir.0.80111-0","volume":"85","author":"H Pang","year":"2004","unstructured":"Pang H, Liu Y, Han X et al (2004) Protective humoral responses to severe acute respiratory syndrome-associated coronavirus: implications for the design of an effective protein-based vaccine. J Gen Virol 85(Pt 10):3109\u20133113. https:\/\/doi.org\/10.1099\/vir.0.80111-0","journal-title":"J Gen Virol"},{"key":"5988_CR28","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1086\/656315","volume":"202","author":"J Liu","year":"2010","unstructured":"Liu J, Sun Y, Qi J et al (2010) The Membrane protein of severe acute respiratory syndrome coronavirus acts as a dominant immunogen revealed by a clustering region of novel functionally and structurally defined cytotoxic T-lymphocyte epitopes. J Infect Dis 202:1171\u20131180. https:\/\/doi.org\/10.1086\/656315","journal-title":"J Infect Dis"},{"key":"5988_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102538","author":"Y Shoenfeld","year":"2020","unstructured":"Shoenfeld Y (2020) Corona (COVID-19) time musings: our involvement in COVID-19 pathogenesis, diagnosis, treatment and vaccine planning. Autoimmun Rev. https:\/\/doi.org\/10.1016\/j.autrev.2020.102538","journal-title":"Autoimmun Rev"},{"key":"5988_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07391102.2020.1754293","volume":"0","author":"A Hasan","year":"2020","unstructured":"Hasan A, Paray BA, Hussain A et al (2020) A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin. J Biomol Struct Dyn 0:1\u201313. https:\/\/doi.org\/10.1080\/07391102.2020.1754293","journal-title":"J Biomol Struct Dyn"},{"key":"5988_CR31","doi-asserted-by":"publisher","first-page":"7432","DOI":"10.3892\/mmr.2017.7546","volume":"16","author":"J Xu","year":"2017","unstructured":"Xu J, Yang J, Chen J et al (2017) Vitamin D alleviates lipopolysaccharide-induced acute lung injury via regulation of the renin-angiotensin system. Mol Med Rep 16:7432\u20137438. https:\/\/doi.org\/10.3892\/mmr.2017.7546","journal-title":"Mol Med Rep"},{"issue":"5","key":"5988_CR32","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1002\/ddr.21656","volume":"81","author":"D Gurwitz","year":"2020","unstructured":"Gurwitz D (2020) Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics. Drug Dev Res 81(5):537\u2013540. https:\/\/doi.org\/10.1002\/ddr.21656","journal-title":"Drug Dev Res"},{"issue":"6","key":"5988_CR33","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41577-020-0320-7","volume":"20","author":"AM Risitano","year":"2020","unstructured":"Risitano AM, Mastellos DC, Huber-Lang M et al (2020) Complement as a target in COVID-19? Nat Rev Immunol 20(6):343\u2013344. https:\/\/doi.org\/10.1038\/s41577-020-0320-7","journal-title":"Nat Rev Immunol"},{"key":"5988_CR34","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1517\/13543776.2013.823159","volume":"23","author":"V Kumar","year":"2013","unstructured":"Kumar V, Jung YS, Liang PH (2013) Anti-SARS coronavirus agents: a patent review (2008\u2013present). Expert Opin Ther Pat 23:1337\u20131348. https:\/\/doi.org\/10.1517\/13543776.2013.823159","journal-title":"Expert Opin Ther Pat"},{"issue":"1","key":"5988_CR35","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41426-018-0031-3","volume":"7","author":"W Seesuay","year":"2018","unstructured":"Seesuay W, Jittavisutthikul S, Sae-Lim N et al (2018) Human transbodies that interfere with the functions of Ebola virus VP35 protein in genome replication and transcription and innate immune antagonism article. Emerg Microbes Infect 7(1):41. https:\/\/doi.org\/10.1038\/s41426-018-0031-3","journal-title":"Emerg Microbes Infect"},{"key":"5988_CR36","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/d41573-020-00016-0","volume":"19","author":"G Li","year":"2020","unstructured":"Li G, De Clercq E (2020) Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nat Rev Drug Discov 19:149\u2013150. https:\/\/doi.org\/10.1038\/d41573-020-00016-0","journal-title":"Nat Rev Drug Discov"},{"key":"5988_CR37","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/cbic.202000047","volume":"21","author":"JS Morse","year":"2020","unstructured":"Morse JS, Lalonde T, Xu S, Liu WR (2020) Learning from the past: possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019-nCoV. ChemBioChem 21:730\u2013738. https:\/\/doi.org\/10.1002\/cbic.202000047","journal-title":"ChemBioChem"},{"key":"5988_CR38","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1136\/thorax.2003.012658","volume":"59","author":"CM Chu","year":"2004","unstructured":"Chu CM, Cheng VCC, Hung IFN et al (2004) Role of lopinavir\/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax 59:252\u2013256. https:\/\/doi.org\/10.1136\/thorax.2003.012658","journal-title":"Thorax"},{"key":"5988_CR39","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/S0140-6736(20)30185-9","volume":"395","author":"C Wang","year":"2020","unstructured":"Wang C, Horby PW, Hayden FG, Gao GF (2020) A novel coronavirus outbreak of global health concern. Lancet 395:470\u2013473. https:\/\/doi.org\/10.1016\/S0140-6736(20)30185-9","journal-title":"Lancet"},{"key":"5988_CR40","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/jmv.25678.4","volume":"14","author":"H Lu","year":"2020","unstructured":"Lu H (2020) Drug treatment options for the 2019-new coronavirus (2019-nCoV). Biosci Trends 14:69\u201371. https:\/\/doi.org\/10.1002\/jmv.25678.4","journal-title":"Biosci Trends"},{"key":"5988_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41594-020-0440-6","author":"Z Jin","year":"2020","unstructured":"Jin Z, Zhao Y, Sun Y et al (2020) Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug Carmofur. Nat Struct Mol Biol. https:\/\/doi.org\/10.1038\/s41594-020-0440-6","journal-title":"Nat Struct Mol Biol"},{"key":"5988_CR42","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.stem.2009.05.003","volume":"5","author":"RH Lee","year":"2009","unstructured":"Lee RH, Pulin AA, Seo MJ et al (2009) Intravenous hMSCs Improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 5:54\u201363. https:\/\/doi.org\/10.1016\/j.stem.2009.05.003","journal-title":"Cell Stem Cell"},{"key":"5988_CR43","doi-asserted-by":"publisher","first-page":"462","DOI":"10.14336\/ad.2020.0301","volume":"11","author":"AK Shetty","year":"2020","unstructured":"Shetty AK (2020) Mesenchymal stem cell infusion shows promise for combating coronavirus (COVID-19)- induced pneumonia. Aging Dis 11:462. https:\/\/doi.org\/10.14336\/ad.2020.0301","journal-title":"Aging Dis"},{"key":"5988_CR44","doi-asserted-by":"publisher","first-page":"470","DOI":"10.14336\/AD.2019.0330","volume":"10","author":"AK Shetty","year":"2019","unstructured":"Shetty AK, Upadhya R, Madhu LN, Kodali M (2019) Novel insights on systemic and brain aging, stroke, amyotrophic lateral sclerosis, and Alzheimer\u2019s disease. Aging Dis 10:470\u2013482. https:\/\/doi.org\/10.14336\/AD.2019.0330","journal-title":"Aging Dis"},{"key":"5988_CR45","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.14336\/AD.2018.1026","volume":"9","author":"AK Shetty","year":"2018","unstructured":"Shetty AK, Kodali M, Upadhya R, Madhu LN (2018) Emerging anti-aging strategies\u2014scientific basis and efficacy. Aging Dis 9:1165\u20131184. https:\/\/doi.org\/10.14336\/AD.2018.1026","journal-title":"Aging Dis"},{"key":"5988_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s12979-020-0173-8","author":"R Thomas","year":"2020","unstructured":"Thomas R, Wang W, Su D (2020) Contributions of age-related thymic involution to immunosenescence and inflammaging. Immun Ageing. https:\/\/doi.org\/10.1186\/s12979-020-0173-8","journal-title":"Immun Ageing"},{"key":"5988_CR47","doi-asserted-by":"publisher","DOI":"10.4110\/in.2019.19.e37","author":"S Oh","year":"2019","unstructured":"Oh S, Lee JK, Shin OS (2019) Aging and the immune system: the impact of immunosenescence on viral infection, immunity and vaccine immunogenicity. Immune Netw. https:\/\/doi.org\/10.4110\/in.2019.19.e37","journal-title":"Immune Netw"},{"key":"5988_CR48","doi-asserted-by":"publisher","first-page":"216","DOI":"10.14336\/AD.2020.0228","volume":"11","author":"Z Leng","year":"2020","unstructured":"Leng Z, Zhu R, Hou W et al (2020) Transplantation of ACE2\u2014mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia. Aging Dis 11:216\u2013228. https:\/\/doi.org\/10.14336\/AD.2020.0228","journal-title":"Aging Dis"},{"key":"5988_CR49","unstructured":"Neil M, Ferguson, Daniel Laydon GN-G et al (2020) Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand. https:\/\/www.imperial.ac.uk\/media\/imperial-college\/medicine\/sph\/ide\/gida-fellowships\/Imperial-College-COVID19-NPI-modelling-16-03-2020.pdf. Accessed 14 May 2020"},{"key":"5988_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0895-3","author":"JS Weitz","year":"2020","unstructured":"Weitz JS, Beckett SJ, Coenen AR et al (2020) Modeling shield immunity to reduce COVID-19 epidemic spread. Nat Med. https:\/\/doi.org\/10.1038\/s41591-020-0895-3","journal-title":"Nat Med"},{"key":"5988_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-0426-7","author":"X Chen","year":"2020","unstructured":"Chen X, Li R, Pan Z et al (2020) Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor. Cell Mol Immunol. https:\/\/doi.org\/10.1038\/s41423-020-0426-7","journal-title":"Cell Mol Immunol"},{"key":"5988_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105954","author":"MD Chi Zhang","year":"2020","unstructured":"Chi Zhang MD, Zhao Wu PhD, Jia-Wen Li MD, Hong Zhao PhD G-QWM (2020) The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality. Int J Antimicrob Agents. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105954","journal-title":"Int J Antimicrob Agents"},{"key":"5988_CR53","doi-asserted-by":"publisher","first-page":"102452","DOI":"10.1016\/j.jaut.2020.102452","volume":"6","author":"B Liu","year":"2020","unstructured":"Liu B, Li M, Zhou Z et al (2020) Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)? J Autoimmun 6:102452. https:\/\/doi.org\/10.1016\/j.jaut.2020.102452","journal-title":"J Autoimmun"},{"key":"5988_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-0402-2","author":"M Zheng","year":"2020","unstructured":"Zheng M, Gao Y, Wang G et al (2020) Functional exhaustion of antiviral lymphocytes in COVID-19 patients. Cell Mol Immunol. https:\/\/doi.org\/10.1038\/s41423-020-0402-2","journal-title":"Cell Mol Immunol"},{"key":"5988_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-0450-7","author":"L Antonioli","year":"2020","unstructured":"Antonioli L, Fornai M (2020) NKG2A and COVID-19: another brick in the wall. Cell Mol Immunol. https:\/\/doi.org\/10.1038\/s41423-020-0450-7","journal-title":"Cell Mol Immunol"},{"key":"5988_CR56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005466","author":"Y Lei","year":"2009","unstructured":"Lei Y, Moore CB, Liesman RM et al (2009) MAVS-mediated apoptosis and its inhibition by viral proteins. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0005466","journal-title":"PLoS ONE"},{"key":"5988_CR57","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.bbamem.2013.07.025","volume":"1838","author":"R Zhang","year":"2014","unstructured":"Zhang R, Wang K, Lv W et al (2014) The ORF4a protein of human coronavirus 229E functions as a viroporin that regulates viral production. Biochim Biophys Acta - Biomembr 1838:1088\u20131095. https:\/\/doi.org\/10.1016\/j.bbamem.2013.07.025","journal-title":"Biochim Biophys Acta - Biomembr"},{"key":"5988_CR58","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1303196","author":"C Shi","year":"2014","unstructured":"Shi C, Qi H, Boularan C et al (2014) SARS-coronavirus open reading frame-9b suppresses innate immunity by targeting mitochondria and the MAVS\/TRAF3\/TRAF6 signalosome. J Immunol. https:\/\/doi.org\/10.4049\/jimmunol.1303196","journal-title":"J Immunol"},{"key":"5988_CR59","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.cell.2020.04.020","volume":"181","author":"TR Abbott","year":"2020","unstructured":"Abbott TR, Dhamdhere G, Liu Y et al (2020) Development of CRISPR as an antiviral strategy to combat SARS-CoV-2 and influenza. Cell 181:865\u2013876. https:\/\/doi.org\/10.1016\/j.cell.2020.04.020","journal-title":"Cell"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-020-05988-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11033-020-05988-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-020-05988-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,8]],"date-time":"2020-12-08T10:15:48Z","timestamp":1607422548000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11033-020-05988-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,13]]},"references-count":59,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5988"],"URL":"https:\/\/doi.org\/10.1007\/s11033-020-05988-1","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,13]]},"assertion":[{"value":"29 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"It is declared that there is no conflict of interest as all authors contributed equally.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No human testing has been involved.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human and animal rights"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}